Safety And Efficacy Of Decitabine-Primed Anti-Pd-1 (Shr-1210) Treatment In Patients With Relapsed/Refractory Classical Hodgkin Lymphoma.Chunmeng Wang,Yang Liu,Jing Nie,Lianjun Shen,Qingming Yang,Weidong HanJOURNAL OF CLINICAL ONCOLOGY(2018)引用 2|浏览53暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络